# FDA Inspection 698052 - BSP Pharmaceuticals SpA - November 12, 2010

Source: https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/a2294fd4-ff4d-41ef-b7b1-6bd9f081dcc1
Source feed: FDA_Inspections

> FDA Inspection 698052 for BSP Pharmaceuticals SpA on November 12, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 698052
- Company Name: BSP Pharmaceuticals SpA
- Inspection Date: 2010-11-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1172555 - 2021-11-12](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/ab1fa615-f7d5-446f-8627-7b386db151d7)
- [FDA Inspection 1091112 - 2017-10-20](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/92267097-f616-4539-b7f9-32cc53cde540)
- [FDA Inspection 1016102 - 2016-12-16](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/dbd27341-8470-41b0-8ef0-5e3534fc848e)
- [FDA Inspection 935609 - 2015-06-26](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/14269f8f-2bbb-49d1-baef-69ba82aa95d2)
- [FDA Inspection 811321 - 2012-12-05](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/c2e638a1-19fe-4b50-a0b4-34233e9b8dbc)

Company: https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c